Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316510 · ClinicalTrials.gov registry record · NA
Probiotics in Infants With Gastroschisis
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01316510 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 24 participants.
The verdict
NCT01316510, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Infants born with gastroschisis usually require surgery shortly after birth. After surgery the intestine is often unable to digest human milk or formula for weeks or months. During this time the baby has to remain in the hospital to receive special nutrition through an IV. How bacteria colonize the intestine in these babies is unknown. Probiotics are bacteria that appear to have beneficial effects on digestion. This study will test whether giving probiotic bacteria to babies after surgery for gastroschisis will change the bacteria in the intestine to be more like those of a healthy breast-fed baby.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Bifidobacteria infantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01316510
The ClinicalTrials.gov registry entry for NCT01316510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01316510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01316510 about?
NCT01316510 is a clinical study titled "Probiotics in Infants With Gastroschisis". Infants born with gastroschisis usually require surgery shortly after birth. After surgery the intestine is often unable to digest human milk or formula for weeks or months. During this time the baby has to remain in the hospital to receive special nutrition through an IV. How bacteria colonize the ...
What is the current status of trial NCT01316510?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2011-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01316510?
The interventions under investigation include: Placebo (OTHER), Bifidobacteria infantis (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01316510?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.